Please assess the completion status of the following clinical trial:

Trial Title: Study of Oral Fampridine-SR in Multiple Sclerosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Have a confirmed diagnosis of multiple sclerosis~* Are able to walk with or without an assistive device~Exclusion Criteria:~* Pregnancy, breastfeeding or females of childbearing potential not using adequate birth control~* Participating in other investigational drug trials~* A medical history or clinical findings that preclude entry into the study~* A medication history that precludes entry into the study~* Previously treated with 4-aminopyridine (4-AP)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Placebo- sugar pill (Type: PLACEBO_COMPARATOR): Placebo control
- Fampridine-SR (Type: EXPERIMENTAL): 10 milligram (mg) tablet b.i.d.

Based on this trial design, predict the completion outcome and termination type (if applicable).